PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $622,000 | -31.1% | 23,350 | -2.3% | 1.81% | -36.8% |
Q2 2018 | $903,000 | +20.4% | 23,900 | +4.1% | 2.87% | +4.0% |
Q1 2018 | $750,000 | -1.4% | 22,950 | +46.9% | 2.76% | -5.2% |
Q4 2017 | $761,000 | -73.1% | 15,625 | -70.2% | 2.91% | -27.6% |
Q3 2017 | $2,828,000 | -28.7% | 52,350 | -25.8% | 4.02% | +18.3% |
Q2 2017 | $3,966,000 | +3.6% | 70,600 | -27.7% | 3.40% | -5.0% |
Q1 2017 | $3,828,000 | +84.0% | 97,675 | +5.4% | 3.57% | +59.4% |
Q4 2016 | $2,080,000 | +12.1% | 92,700 | +13.5% | 2.24% | +25.8% |
Q3 2016 | $1,855,000 | +4.6% | 81,700 | +8.7% | 1.78% | -4.6% |
Q2 2016 | $1,774,000 | +19.1% | 75,150 | +2.9% | 1.87% | +13.8% |
Q1 2016 | $1,490,000 | -47.4% | 73,025 | +32.7% | 1.64% | -45.4% |
Q4 2015 | $2,831,000 | – | 55,025 | – | 3.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 270,832 | $6,467,000 | 5.27% |
Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |